Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Get Adobe Flash player


Sales rise for Roche's cancer drug Add to ...

11.27 billion Swiss francs ($12.1-billion U.S.) is the third quarter sales figures from Swiss drug maker Roche. The world's biggest maker of cancer drugs is banking on a new generation of breast cancer medicines to drive sales growth. Sonia Legg reports



In the know

More from The Globe and Mail

Most popular stories